We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.6B
AUM Growth
+$2.71B
Cap. Flow
+$599M
Cap. Flow %
2.91%
Top 10 Hldgs %
26.44%
Holding
1,633
New
69
Increased
616
Reduced
373
Closed
77

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$153M
2
AVGO icon
Broadcom
AVGO
+$87.4M
3
ADBE icon
Adobe
ADBE
+$71.2M
4
AAPL icon
Apple
AAPL
+$67.6M
5
CNM icon
Core & Main
CNM
+$58.9M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$62M
2
RGA icon
Reinsurance Group of America
RGA
+$51.5M
3
MDT icon
Medtronic
MDT
+$35.3M
4
MOH icon
Molina Healthcare
MOH
+$34.7M
5
BABA icon
Alibaba
BABA
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 32.69%
2 Healthcare 19.57%
3 Financials 10.5%
4 Industrials 10.22%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCC
1401
CCC Intelligent Solutions
CCC
$4B
$278K ﹤0.01%
+24,400
New +$285K
DEA
1402
Easterly Government Properties
DEA
$1.17B
$277K ﹤0.01%
8,240
MSEX icon
1403
Middlesex Water
MSEX
$1.11B
$277K ﹤0.01%
4,215
+515
+14% +$33.9K
STC icon
1404
Stewart Information Services
STC
$2.03B
$276K ﹤0.01%
4,700
TROX icon
1405
Tronox
TROX
$963M
$276K ﹤0.01%
19,500
ASTH icon
1406
Astrana Health
ASTH
$1.83B
$276K ﹤0.01%
7,200
BCRX icon
1407
BioCryst Pharmaceuticals
BCRX
$2.52B
$275K ﹤0.01%
45,900
+10,400
+29% +$60.3K
AGNT
1408
AGNT Inc
AGNT
$707M
$275K ﹤0.01%
17,700
+1,900
+12% +$26.6K
NTB icon
1409
Bank of N.T. Butterfield & Son
NTB
$2.5B
$275K ﹤0.01%
8,600
-2,300
-21% -$65.2K
JACK icon
1410
Jack in the Box
JACK
$375M
$274K ﹤0.01%
3,351
ACH
1411
Accendra Health
ACH
$85.4M
$274K ﹤0.01%
14,200
PGRE
1412
DELISTED
Paramount Group
PGRE
$274K ﹤0.01%
53,020
+11,000
+26% +$52.2K
SAGE
1413
DELISTED
Sage Therapeutics
SAGE
$274K ﹤0.01%
12,644
+2,900
+30% +$57.5K
ASAN icon
1414
Asana
ASAN
$2.03B
$272K ﹤0.01%
14,300
YOU icon
1415
Clear Secure
YOU
$4.72B
$271K ﹤0.01%
+13,100
New +$255K
MORF
1416
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$271K ﹤0.01%
+9,400
New +$224K
ICHR icon
1417
Ichor Holdings
ICHR
$2.7B
$269K ﹤0.01%
8,000
JBLU icon
1418
JetBlue
JBLU
$2.19B
$269K ﹤0.01%
48,400
MATW icon
1419
Matthews International
MATW
$725M
$269K ﹤0.01%
7,330
MBUU icon
1420
Malibu Boats
MBUU
$579M
$269K ﹤0.01%
4,900
MFA
1421
MFA Financial
MFA
$936M
$269K ﹤0.01%
23,847
SABR icon
1422
Sabre
SABR
$848M
$269K ﹤0.01%
61,100
ADUS icon
1423
Addus HomeCare
ADUS
$2.21B
$268K ﹤0.01%
2,883
AGIO icon
1424
Agios Pharmaceuticals
AGIO
$2.01B
$268K ﹤0.01%
12,023
+2,900
+32% +$65K
RKLB icon
1425
Rocket Lab Corp
RKLB
$51.6B
$268K ﹤0.01%
48,400
+18,500
+62% +$83.5K

Similar funds

Handelsbanken Fonder's Q4 2023 Portfolio in Review

As of Q4 2023, Handelsbanken Fonder held 1,633 positions worth $20.6B, up 15% from $17.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Handelsbanken Fonder's Q4 2023 filing shows 69 new, 616 increased, 373 reduced and 77 closed positions. Its largest new stake was Berkshire Hathaway Class B: 437,243 shares worth $156M. The largest sale was Linde, an estimated $62M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q4 2023 buy was Berkshire Hathaway Class B: 437,243 shares worth $156M.
  • Handelsbanken Fonder added most to Broadcom in Q4 2023, an estimated $87.4M increase.
  • Handelsbanken Fonder's biggest Q4 2023 reduction was Linde, cutting an estimated $62M.
  • Handelsbanken Fonder fully exited T1 Energy in Q4 2023, selling an estimated $27.4M.
  • Handelsbanken Fonder's ten largest holdings make up 26% of its $20.6B portfolio in Q4 2023.
  • Handelsbanken Fonder opened 69 new positions and closed 77 in Q4 2023.
  • Handelsbanken Fonder's portfolio value rose 15% quarter-over-quarter to $20.6B.

Based on Handelsbanken Fonder's 13F filing for Q4 2023, filed 1 Feb 2024.